Key Patents
The team's principal held and filed patents include the following.
- US 7,381,819 B2 — Composition and method for treating/preventing endometritis
- KOREA 10-2015-0009682 — Stem-cell induction medium containing RGMc, and induction method
- KOREA 10-2006-0119155 — Composition containing RNA molecules for treating/preventing endometrial cancer
- KOREA 10-2008-0011933 — PNA-variant compound with antibacterial activity
- KOREA 10-0895324 — Inducing differentiation of insulin-secreting cells from adult stem cells
- KOREA 10-0683198 — Method and medium for differentiating neural progenitors into dopaminergic neurons
- KOREA 10-0683199 — Method and medium for differentiating neural progenitors into cholinergic neurons
- KOREA 10-2008-0095467 — Hepatocyte differentiation from adipose/placental-derived adult stem cells
- KOREA 10-2010-0045281 — Method for inducing insulin-secreting-cell differentiation from adult stem cells
Evidence-Based Achievements
This patent portfolio is the fruit of long-standing academic research and underpins ABin Cell's distinctive assets — the proprietary induction medium (RGMc), differentiation technologies for neural and metabolic disease, and the RNA/PNA nucleic-acid platform.
This content is provided for general informational purposes only, and individual treatment outcomes may vary.